Abstract
BackgroundMyelodysplastic syndromes (MDS) are clonal stem cell disorders exhibiting cytopenias, ineffective hematopoiesis and morphological dysplasia. Bone marrow cytogenetics, inspite of being incorporated as mandatory tool in diagnosis are done less frequently due to limited availability of this technique in Pakistan. The aim of the study was to study baseline clinicohematological and cytogenetic characteristics of patients presenting with de novo MDS.ResultsA retrospective cross sectional study was done at National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan from 2010 to 2016. Total of 177 patients were included in the study having median age 51 years and male to female ratio of 3:1. Pancytopenia was observed in 80 (45%) patients and bicytopenia in 74 (42%). Mean Hb% was 7.8 ± 2.18 g/dl, total leukocyte count (TLC) 8.8 ± 13.6 × 109/l, platelet count was 82 ± 95.7 × 109/l. Of total 170 (96%) were transfusion dependent. Refractory cytopenias with multilineage dysplasia (RCMD) was the most common world health organization (WHO) category. Karyotype was done in 98 (55%) patients out of which 44 (45%) had abnormal karyotype, complex karyotype (CK) was most commonly observed in 12 (12.2%) followed by monosomy 7 in 7 (7.1%).ConclusionsWe found younger median age at diagnosis, higher mean TLC and no significant history of recurrent infections. CK and monosomy 7 carry bad prognostic implications and early disease transformation to acute myeloid leukemia (AML). Monosomy 7 being associated with bad overall survival, such patients must be identified early with close clinical follow up and offered stem cell transplant. This is the largest cohort of patients of MDS evaluated for baseline clinical and cytogenetic characteristics in our country.
Highlights
Myelodysplastic syndromes (MDS) are clonal stem cell disorders exhibiting cytopenias, ineffective hematopoiesis and morphological dysplasia
Myelodysplastic syndromes (MDS) are group of clonal hematopoietic stem cell disorders exhibiting ineffective hematopoiesis, morphological dysplasia and progressive tendency to evolve into acute myeloid leukemia (AML) [1,2,3,4,5]
The GTG (G-bands via trypsin using Giemsa) banding technique was applied, karyotypes were described according to the International System for Human Cytogenetic Nomenclature (ISCN) 2013, karyogram were made using Meta system
Summary
Myelodysplastic syndromes (MDS) are clonal stem cell disorders exhibiting cytopenias, ineffective hematopoiesis and morphological dysplasia. Myelodysplastic syndromes (MDS) are group of clonal hematopoietic stem cell disorders exhibiting ineffective hematopoiesis, morphological dysplasia and progressive tendency to evolve into acute myeloid leukemia (AML) [1,2,3,4,5]. Anwar et al Molecular Cytogenetics (2017) 10:17 not been well established [6] Keeping this in mind, this study was done to assess the baseline clinicohematological characteristics of patients presenting with MDS, evaluate their cytogenetic profile and compare our analysis to what has been reported previously. This is the largest cohort of patients diagnosed with MDS and evaluated for their baseline hematological, clinical and cytogenetic profile in our country
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.